CHC年鑑:2024年
市場調查報告書
商品編碼
1411022

CHC年鑑:2024年

CHC YearBook 2024

出版日期: | 出版商: Nicholas Hall Group of Companies | 英文 316 Pages | 訂單完成後即時交付

價格
簡介目錄

本報告提供消費者醫療保健(CHC)市場相關調查,彙整商店銷售,直接·網路零售,郵購等,CHC市場整體流通管道資料,各地區趨勢,主要企業的簡介,領導品牌概要等資料。

目錄

CHC市場定義

第1章 世界檢討

  • 全球概要
  • 競爭情形
  • 交換器
  • 品牌和革新
  • 零售業
  • 預測

第2章 地區檢討

  • 北美
  • 東亞及東南亞
  • 西歐
  • 中央·東歐
  • 南美
  • 日本
  • 印度半島
  • 澳洲

第3章 主要市場

  • 美國
  • 中國
  • 日本
  • 德國
  • 俄羅斯
  • 巴西
  • 法國
  • 印度
  • 義大利
  • 墨西哥
  • 波蘭
  • 英國
  • 澳洲
  • 加拿大
  • 印尼

第4章 類別檢討

  • 止痛藥
  • 咳嗽,感冒,過敏
  • 腸胃藥
  • 維他命,礦物,補充品
  • 皮膚科
  • 生活方式CHC

第5章 主要企業

  • Haleon
  • Kenvue
  • Bayer
  • Sanofi
  • Reckitt
  • P&G
  • China Resources 999
  • Taisho
  • Nestle
  • Otsuka
  • Abbott
  • Bausch Health
  • Prestige Consumer Healthcare
  • Stada
  • Teva
  • Perrigo
  • Viatris
  • Church & Dwight
  • Hypera Pharma
  • Mondelez

第6章 合併和收購

第7章 領導品牌

  • Vicks
  • Tylenol
  • Nature Made
  • Advil
  • Mucinex
  • Voltaren
  • Centrum
  • Panadol
  • Halls
  • Dong-e E-Jiao
  • Nicorette
  • 999 Gan Mao Ling
  • Nurofen
  • Zyrtec
  • Nature's Bounty
  • Doliprane
  • Claritin
  • Strepsils
  • Yiling Lianhua Qingwen
  • Allegra
  • Olly
  • Caltrate
  • Fupai E-Jiao
  • Motrin
  • Bayer Aspirin

第8章 熱門話題

第9章 從處方藥轉換到OTC藥

  • 概要
  • 西歐
  • 北美
  • 日本
  • 澳洲
  • 新興市場
  • 主要的轉換

第10章 新產品的開發與革新

  • 止痛藥
  • 咳嗽,感冒,過敏
  • 腸胃藥
  • 維他命,礦物,補充品
  • 皮膚科
  • 生活方式CHC

第11章 世界零售業

第12章 公司所有權

第13章 與品牌行銷負責人

第14章 製造商協會

第15章 詞彙表

簡介目錄

CHC FACTS & FIGURES IN FOCUS

A vital resource for Consumer Health marketers, offering instant access to the facts & figures needed to support quick and accurate decision-making, including full year-end 2023 sales data from the only dedicated worldwide CHC sales database.

Expanded coverage

'CHC YearBook 2024' includes ll channels data for the total CHC market, including splits for Store, Direct Internet & mail order sales. Selected chapters feature added detail of sales via Direct (MLM) and Internet & mail order channels, reflecting the latest information from our dedicated 'DB6' database.

'CHC YearBook' is used by top OTC, pharma and consumer health companies, investment banks and consultants around the world.

With extensive knowledge and experience in benchmarking the world of consumer health, Nicholas Hall's 'CHC YearBook 2024' provides a focused set of data and analysis. Find all the facts, all the figures, at your fingertips.

Global Review

  • Highlighting major developments and global trends, and forecasting the CHC outlook for the future

Regional Review

  • 8 major regions come under the spotlight, with the focus on key markets, trends and developments

Leading Markets

  • Coverage of the Top 15 markets includes topline data by category, leading marketers and brands - PLUS a country-by-country review of regulations, switch environment, advertising and distribution

Category Review

  • Global coverage of Analgesics, CCA, Gastrointestinals, VMS, Derma and Lifestyle CHC

Leading Companies

  • Profiles of the Top 20 CHC players across the world.
  • Leading 250 CHC marketers by sales with CAGR 2019-23

Mergers & Acquisitions

  • All the major M&A activity, joint-ventures and alliances since 2019 - PLUS coverage of multiples paid for acquisitions in the CHC industry

Leading Brands

  • The leading 250 CHC brands by sales - PLUS concise profiles of the Top 25 brands

Hot Topics

  • Analysis of the latest hot-button issues affecting consumer health

Rx-to-OTC Switch

  • Overview of the switch environment in key markets - PLUS profiles of significant Rx-to-OTC switches

New Product Development & Innovation

  • Overview of latest activity in delivery formats and NPD across CHC categories

Global Retailing

  • Comprehensive overview of the fast-changing global retailing environment

Essential Reference Tables

  • Information on classification of ingredients, company ownership, brands & marketers and manufacturers' associations - PLUS a CHC glossary

Table of Contents

CHC Market Definition

1. Global Review

  • World Overview
  • Competitive Landscape
  • Switch
  • Brands & Innovation
  • Retailing
  • Outlook

2. Regional Review

  • North America
  • East & South East Asia
  • Western Europe
  • Central & Eastern Europe
  • Latin America
  • Japan
  • Indian Subcontinent
  • Australasia

3. Leading Markets

  • USA
  • China
  • Japan
  • Germany
  • Russia
  • Brazil
  • France
  • India
  • Italy
  • Mexico
  • Poland
  • UK
  • Australia
  • Canada
  • Indonesia

4. Category Review

  • Analgesics
  • Cough, cold & allergy
  • Gastrointestinals
  • Vitamins, minerals & supplements
  • Dermatologicals
  • Lifestyle CHC

5. Leading Companies

  • Haleon
  • Kenvue
  • Bayer
  • Sanofi
  • Reckitt
  • P&G
  • China Resources 999
  • Taisho
  • Nestle
  • Otsuka
  • Abbott
  • Bausch Health
  • Prestige Consumer Healthcare
  • Stada
  • Teva
  • Perrigo
  • Viatris
  • Church & Dwight
  • Hypera Pharma
  • Mondelez

6. Mergers & Acquisitions

7. Leading Brands

  • Vicks
  • Tylenol
  • Nature Made
  • Advil
  • Mucinex
  • Voltaren
  • Centrum
  • Panadol
  • Halls
  • Dong-e E-Jiao
  • Nicorette
  • 999 Gan Mao Ling
  • Nurofen
  • Zyrtec
  • Nature's Bounty
  • Doliprane
  • Claritin
  • Strepsils
  • Yiling Lianhua Qingwen
  • Allegra
  • Olly
  • Caltrate
  • Fupai E-Jiao
  • Motrin
  • Bayer Aspirin

8. Hot Topics

  • Obesity crisis represents huge opportunity for CHC
  • Changing demographics necessitating shift in CHC strategies
  • Trend for health through digestion driving innovation in probiotics
  • Sustainability & transparency remain targets for investment in CHC

9. Rx-to-OTC Switch

  • Overview
  • Western Europe
  • North America
  • Japan
  • Australasia
  • Emerging markets
  • The Big Switches
    • Allegra
    • Alli, Xenical
    • Astepro
    • Differin
    • ellaOne
    • Flonase / Flixonase
    • Formigran
    • Hana, Lovima
    • Loxonin S
    • Maloff Protect
    • MiraLAX
    • Nasacort
    • Nexium 24HR
    • Pataday
    • Plan B, NorLevo, Postinor, Levonelle
    • Prevacid 24HR
    • Rhinocort
    • Silvasta, MaxOn Active / Tadalafil MaxOn, Viagra Connect, Cialis
    • Voltaren
    • Xyzal
    • Zyrtec

10. New Product Development & Innovation

  • Analgesics
  • Cough, Cold & Allergy
  • Gastrointestinals
  • Vitamins, Minerals & Supplements
  • Dermatologicals
  • Lifestyle CHC

11. Global Retailing

12. Company Ownership

13. Brands & Marketers

14. Manufacturers' Associations

15. Glossary

Charts

  • Chart 1: Global CHC sales by region 2023
  • Chart 2: Global CHC sales by category 2023
  • Chart 3: Global CHC forecasts by region
  • Chart 4: Global CHC forecasts by category
  • Chart 5: North America CHC market by category 2023
  • Chart 6: North America leading CHC marketers & brands 2023
  • Chart 7: E&SE Asia CHC market by category 2023
  • Chart 8: E&SE Asia leading CHC marketers & brands 2023
  • Chart 9: Western Europe CHC market by category 2023
  • Chart 10: Western Europe leading CHC marketers & brands 2023
  • Chart 11: C&E Europe CHC market by category 2023
  • Chart 12: C&E Europe leading CHC marketers & brands 2023
  • Chart 13: Latin America CHC market by category 2023
  • Chart 14: Latin America leading CHC marketers & brands 2023
  • Chart 15: Japan CHC market by category 2023
  • Chart 16: Japan leading CHC marketers & brands 2023
  • Chart 17: Indian Subcontinent CHC market by category 2023
  • Chart 18: Indian Subcontinent leading CHC marketers & brands 2023
  • Chart 19: Australasia CHC market by category 2023
  • Chart 20: Australasia leading CHC marketers & brands 2023
  • Chart 21: Global leading 15 CHC markets 2023
  • Chart 22: USA CHC market by category 2023
  • Chart 23: USA leading CHC marketers & brands 2023
  • Chart 24: China CHC market by category 2023
  • Chart 25: China leading CHC marketers & brands 2023
  • Chart 26: Japan CHC market by category 2023
  • Chart 27: Japan leading CHC marketers & brands 2023
  • Chart 28: Germany CHC market by category 2023
  • Chart 29: Germany leading CHC marketers & brands 2023
  • Chart 30: Russia CHC market by category 2023
  • Chart 31: Russia leading CHC marketers & brands 2023
  • Chart 32: Brazil CHC market by category 2023
  • Chart 33: Brazil leading CHC marketers & brands 2023
  • Chart 34: France CHC market by category 2023
  • Chart 35: France leading CHC marketers & brands 2023
  • Chart 36: India CHC market by category 2023
  • Chart 37: India leading CHC marketers & brands 2023
  • Chart 38: Italy CHC market by category 2023
  • Chart 39: Italy leading CHC marketers & brands 2023
  • Chart 40: Mexico CHC market by category 2023
  • Chart 41: Mexico leading CHC marketers & brands 2023
  • Chart 42: Poland CHC market by category 2023
  • Chart 43: Poland leading CHC marketers & brands 2023
  • Chart 44: UK CHC market by category 2023
  • Chart 45: UK leading CHC marketers & brands 2023
  • Chart 46: Australia CHC market by category 2023
  • Chart 47: Australia leading CHC marketers & brands 2023
  • Chart 48: Canada CHC market by category 2023
  • Chart 49: Canada leading CHC marketers & brands 2023
  • Chart 50: Indonesia CHC market by category 2023
  • Chart 51: Indonesia leading CHC marketers & brands 2023
  • Chart 52: Global CHC analgesics category split 2023
  • Chart 53: Leading analgesic brands 2023
  • Chart 54: Global CHC CCA category split 2023
  • Chart 55: Leading CCA brands 2023
  • Chart 56: Global CHC GIs category split 2023
  • Chart 57: Leading GI brands 2023
  • Chart 58: Global CHC VMS category split 2023
  • Chart 59: Leading VMS brands 2023
  • Chart 60: Global CHC dermatologicals category split 2023
  • Chart 61: Leading dermatological brands 2023
  • Chart 62: Global lifestyle CHC category split 2023
  • Chart 63: Leading lifestyle CHC brands 2023
  • Chart 64: Top 250 CHC marketers 2023
  • Chart 65: CHC merger, acquisition, alliance & joint-venture activity 2019-2024
  • Chart 66: Multiples paid for CHC acquisitions 2019-2023
  • Chart 67: Leading CHC brands 2023
  • Chart 68: Legal status of ingredients in selected world markets
  • Chart 69: Legal status of ingredients in selected European markets (I)
  • Chart 70: Legal status of ingredients in selected European markets (II)
  • Chart 71: Big Switches global CHC sales 2023
  • Chart 72: Company Ownership Index
  • Chart 73: Brands & Marketers Index